Transient Transfection Services

Rapid protein production is critical for accelerating biologics discovery and enabling timely decision-making during early-stage drug development. Protheragen leverages a robust CHO-based expression platform to provide high-yield transient transfection services, rapidly generating recombinant proteins for candidate screening, functional assessment, analytical characterization, and early-stage process development.

Overview of Transient Transfection

Transient transfection is a widely used gene expression technique that enables the rapid production of recombinant proteins by introducing expression plasmids into mammalian cells without permanent integration into the host genome. Because the introduced DNA is expressed only temporarily, this approach allows proteins to be generated within days, making it an ideal solution for early-stage biologics research and development.

Compared with stable cell line generation, transient transfection significantly shortens development timelines while providing sufficient quantities of high-quality proteins for discovery and preclinical studies. It is commonly applied to the expression of monoclonal antibodies, bispecific antibodies, fusion proteins, enzymes, cytokines, and other recombinant proteins for functional evaluation, structural characterization, and developability assessment.

Fig.1 Schematic workflow of transient expression process in mammalian cells (Fu, Y., et al., 2024)

Our Services

Our transient transfection services utilize a robust CHO cell expression platform with optimized vector design, transfection protocols, and purification workflows to achieve high expression yields and consistent product quality. By rapidly delivering research-grade protein materials, we help clients accelerate candidate screening, analytical characterization, and early CMC activities while establishing a solid foundation for subsequent stable cell line development and large-scale manufacturing.

Key Advantages of Our Expression Platform

1. Same Expression Platform for Future CMC Development

Our CHO transient expression platform utilizes the same host cell background employed for stable cell line development, enabling better prediction of future manufacturing performance and reducing process transfer risks.

2. Rapid Turnaround

Efficient workflows enable fast production of recombinant proteins to support critical early-stage studies.

Typical delivery timeline

(Actual timelines may vary depending on protein characteristics.)

Transient Process

Applications

Our transiently expressed proteins support a wide variety of development activities, including:

Why Choose Us

• Fast Material Generation
  Rapid production of recombinant proteins to accelerate project timelines.
• Optimized Mammalian Expression Platforms
  High-yield expression systems suitable for diverse biologic modalities.
• High Product Quality
  Reliable purification and analytical characterization ensure consistent protein quality.
• Scalable Development Strategy
  Transient expression data support a smooth transition into stable cell line development and process optimization.

Rapid access to high-quality recombinant proteins is essential for efficient biologics development. Our transient transfection services enable clients to quickly obtain research materials for candidate evaluation, functional testing, and early CMC studies while establishing a solid foundation for subsequent stable cell line development and large-scale manufacturing. With integrated development expertise and scalable expression platforms, Protheragen help shorten development timelines and reduce technical risks throughout the biologics development process. Contact us to explore a customized transient transfection strategy for your biologics program.